Located in Salt Lake City , Utah , a center of leading blood pump research and development, MedQuest was incorporated in 1993 to commercialize the HeartQuest™ Ventricular Assist Device (VAD). The founding group’s earlier experience developing a pulsatile total artificial heart (TAH) from concept to animal trials convinced them that:

• VADs were a simpler, safer, and more effective blood pump than TAHs and would meet 90% of
patient needs.

• To succeed, blood pumps needed to incorporate a breakthrough technology for increased
reliability.

• The only way to achieve such reliability and provide maximum benefits was to effectively
implement magnetic levitation technology in a blood pump.

Since inception, MedQuest has executed HeartQuest™ VAD development from concept to blood pump feasibility in animals today. Major HeartQuest™ VAD milestones achieved led to medical foundation-based support, NIH grants, and Series A financing.

Our Mission
Provide reliable, cost-effective, and innovative therapies for congestive heart failure patients worldwide.

Our Goal
To become the world leader in providing viable therapies for congestive heart failure that provides a long and high quality of life to patients.

Our Values
Respect, honesty and integrity, teamwork and trust, profit, responsibility, accountability, creativity, and innovation.

Our Quality Policy
MedQuest is committed to the development and realization of products that will improve quality and extend life for congestive heart failure patients.

We will accomplish this through the development and continual improvement of a compliant Quality Management System.

We will continually improve our level of internal and external customer service by identifying, understanding, and fulfilling our customers’ needs.

We will foster teamwork and timely problem resolution through open and honest communication throughout the organization.